Particle Engineering of Polymers into Multifunctional Interactive Excipients

Handbook of Polymers for Pharmaceutical Technologies

Volumn 2, Issue , 2015, Pages 1-31

  Mangal, Sharad ^a   Larson, Ian ^a   Meiser, Felix ^a   Morton, David A V ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Binder; Interactive mixtures; Multifunctional excipients; Particle engineering; Powder technology; Tablets

Indexed keywords

FILLED POLYMERS; GRANULATION; MIXTURES; NATURAL POLYMERS; PARTICLE SIZE;

COHESIVE-ADHESIVE BALANCES; HOMOGENEOUS DISTRIBUTION; MULTIFUNCTIONAL EXCIPIENTS; PARTICLE ENGINEERING; PARTICLE SIZE REDUCTION; PHYSICO-CHEMICAL AND MECHANICAL PROPERTIES; POWDER TECHNOLOGY; TABLETS;

BINDERS;

EID: 84965039598     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781119041412.ch1     Document Type: Chapter

References (107)

1. A.G. Mirani, S.P. Patankar, V.S. Borole, A.S. Pawar, V.J. Kadam, Direct compression high functionality excipient using coprocessing technique: A brief review, Current Drug Delivery, 8, 426-435, 2011.
2. G.P. Andrews, Advances in solid dosage form manufacturing technology, Philosophical Transactions of The Royal Society A-Mathematical Physical and Engineering Sciences, 365, 2935-2949, 2007.
3. G.K. Bolhuis, N.A. Armstrong, Excipients for direct compaction-an update, Pharmaceutical Development and Technology, 11, 111-124, 2006.
4. J. Rojas, I. Buckner, V. Kumar, Co-proccessed excipients with enhanced direct compression functionality for improved tableting performance, Drug Development and Industrial Pharmacy, 38, 1159-1170, 2012.
5. L. Meeus, Direct compression versus granulation, Pharmaceutical Technology Europe, 23, 21-22, 2011.
6. G.K. Bolhuis, Z.T. Chowhan, "Materials for direct compression," in: G. Alderborn, C. Nyström, eds., Pharmaceutical Powder Compaction Technology, Marcel Dekker Inc., New York, pp. 419-500, 1996.
7. S.F. Mattsson, C. Nyström, Evaluation of critical binder properties affecting the compactibility of binary mixtures, Drug Development and Industrial Pharmacy, 27, 181-194, 2001.
8. Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market for Polymers (MCC, HPMC, CMC, Ethyl Cellulose, Povidone and Others), Alcohols (Glycerin, Sorbitol, Mannitol, Propylene Glycol), Minerals (Clay, Silicon Dioxide, Titanium Dioxide) and Sugars (Lactose, Sucrose) - Global Industry Analysis, Size, Share, Trends, Analysis, Growth and Forecast, 2012 - 2018, 2013.
9. R.C. Rowe, P.J. Sheskey, M.E. Quinn, Handbook of Pharmaceutical Excipients, American Pharmaceutical Association and London: Pharmaceutical Press, Washington, D.C., 2009.
10. C. Nyström, J. Mazur, J. Sjögren, Studies on direct compression of tablets II. The influence of the particle size of a dry binder on the mechanical strength of tablets, International Journal of Pharmaceutics, 10, 209-218, 1982.
11. S. Malamataris, B.S. Bin, N. Pilpel, Plasto-elasticity and tableting of paracetamol, Avicel and other powders, Journal of Pharmacy and Pharmacology, 36, 616-617, 1984.
12. M. Duberg, C. Nyström, Studies on direct compression of tablets. XII. The consolidation and bonding properties of some pharmaceutical compounds and their mixtures with Avicel 105., International Journal of Pharmeutical Technology and Product Manufacturing, 6, 17-25, 1985.
13. H.C. Yu, M.H. Rubinstein, I.M. Jackson, H.M. Elsabbagh, Multiple compression and plasto-elastic behaviour of paracetamol and microcrystalline cellulose mixtures, Journal of Pharmacy and Pharmacology, 40, 669-673, 1988.
14. H. Olsson, S. Mattsson, C. Nyström, Evaluation of the effect of addition of polyethylene glycols of differing molecular weights on the mechanical strength of sodium chloride and sodium bicarbonate tablets, International Journal of Pharmaceutics, 171, 31-44, 1998.
15. A. Hlinak, K. Kuriyan, K. Morris, G. Reklaitis, P. Basu, Understanding critical material properties for solid dosage form design, Journal of Pharmaceutical Innovation, 1, 12-17, 2006.
16. C. Nyström, G. Alderborn, M. Duberg, P.-G. Karehill, Bonding surface area and bonding mechanism: Two important factors for the understanding of powder comparability, Drug Development and Industrial Pharmacy, 19, 2143-2196, 1993.
17. F. Fichtner, D. Mahlin, K. Welch, S. Gaisford, G. Alderborn, Effect of surface energy on powder compactibility, Pharmaceutical Research, 25, 2750-2759, 2008.
18. C.C. Sun, Decoding powder tabletability: Roles of particle adhesion and plasticity, Journal of Adhesion Science and Technology, 25, 483-499, 2011.
19. R.J. Roberts, R.C. Rowe, The effect of punch velocity on the compaction of a variety of materials, Journal of Pharmacy and Pharmacology, 37, 377-384, 1985.
20. J.M.G. Cowie, Polymers: Chemistry and Physics of Modern Materials, 3rd ed., Nelson Thornes, London, 2001.
21. K. Van der Voort Maarschalk, H. Vromans, G.K. Bolhuis, C.F. Lerk, Influence of plasticizers on tableting properties of polymers, Drug Development and Industrial Pharmacy, 24, 261-268, 1998.
22. 4th ed., Elsevier, Amsterdam, pp. 129-188, 2009.
23. C. Moreton, Functionality and performance of excipients in a quality-by-design world part 2: Excipient variability, QbD and robust formulations, American Pharmaceutical Review, 12, 40-45, 2009.
24. S. Saha, A.F. Shahiwala, Multifunctional coprocessed excipients for improved tabletting performance, Expert Opinion on Drug Delivery, 6, 197-208, 2009.
25. G. Thoorens, F. Krier, B. Leclercq, B. Carlin, B. Evrard, Microcrystalline cellulose, a direct compression binder in a quality by design environment-A review, International Journal of Pharmaceutics, 473, 64-72, 2014.
26. K.M. Picker-Freyer, T. Dürig, Physical mechanical and tablet formation properties of hydroxypropylcellulose: In pure form and in mixtures, AAPS PharmSciTech, 8 (4), 2007.
27. M.A. Kabir, J.P. Reo, "Hydroxypropyl cellulose," in: R.C. Rowe, P.J. Sheskey, M.E. Quinn, eds., Handbook of Pharmaceutical Excipients, American Pharmaceutical Association and London: Pharmaceutical Press, Washington, D.C., pp. 317-322, 2009.
28. K.P. Hapgood, S. Obara, "Hydroxypropyl cellulose, low-substituted," in: R.C. Rowe, P.J. Sheskey, M.E. Quinn, eds., Handbook of Pharmaceutical Excipients, American Pharmaceutical Association and London: Pharmaceutical Press, Washington, D.C., pp. 322-324, 2009.
29. http://www.pharma-ingredients.basf.com/Statements/Technical%201nformations/EN/Pharma%20Solutions/03_050602e_Kollidon%20VA%2064_VA%2064%20Fine.pdf.
30. G.E. Peck, N.R. Anderson, G.S. Banker, "Principles of improved tablet production system design," in: H.A. Liebermann, L. Lachman, J.B. Schwartz, eds., Pharmaceutical Dosage Froms: Tablets, Lea & Febiger, pp. 1-76, 1990.
31. G.W. Skinner, W.W. Harcum, P.E. Barnum, J.-H. Guo, The evaluation of fine-particle hydroxypropylcellulose as a roller compaction binder in pharmaceutical applications, Drug Development and Industrial Pharmacy, 25, 1121-1128, 1999.
32. S. Mattsson, C. Nyström, Evaluation of strength-enhancing factors of a ductile binder in direct compression of sodium bicarbonate and calcium carbonate powders, European Journal of Pharmaceutical Sciences, 10, 53-66, 2000.
33. K. Kolter, D. Flick, Structure and dry binding activity of different polymers, including Kollidon VA 64, Drug Development and Industrial Pharmacy, 26, 1159-1165, 2000.
34. http://www.pharma-ingredients.basf.com/Documents/ENP/Brochure/EN/BASF_Ludipress_LCE.pdf
35. http://www.meggle-pharma.com/en/products-and-services/products/product-overview/cellactose-80-coprocessed-.
36. http://www.meggle-pharma.com/en/products-and-services/products/product-overview/microcelac-100-coprocessed-.
37. http://www.td-alfarma.ru/img/sert/lac200m.pdf.
38. http://www.meggle-pharma.de/de/products-and-services/products/product-overview/tablettose-70-agglomerated-.
39. S. Edge, A.H. Kibbe, J. Shur, Lactose, "Monohydrate," in: R.C. Rowe, P.J. Sheskey, M.E. Quinn, eds., Handbook of Pharmaceutical Excipients, American Pharmaceutical Association and London: Pharmaceutical Press, Washington, D.C., pp. 364-369, 2009.
40. http://www.signetchem.com/downloads/datasheets/Fmc-biopolymer/Avicel-Ph-200-Specifications.pdf.
41. http://www.spipharma.com/documents/document/1155.
42. S. Jacob, A. Shirwaikar, A. Joseph, K. Srinivasan, Novel co-processed excipients of mannitol and microcrystalline cellulose for preparing fast dissolving tablets of glipizide, Indian Journal of Pharmaceutical Sciences, 69, 633-639, 2007.
43. S.K. Nachaegari, A.K. Bansal, Coprocessed excipients for solid dosage forms, Pharmaceutical Technology, 28 (1), 52-64, 2004.
44. R. Friedman, "Pharmaceutical quality systems: US perspective,: in: Pharmaceutical Quality System (ICH Q10) Conference, Brussels, Belgium, 2011.
45. L.X. Yu, Pharmaceutical quality by design: Product and process development, understanding, and control, Pharmaceutical Research, 25, 781-791, 2008.
46. A. Belič, I. Škrjanc, D.Z. Božič, F. Vrečer, Tableting process optimisation with the application of fuzzy models, International Journal of Pharmaceutics, 389, 86-93, 2010.
47. C.M.V. Moore, An FDA perspective on drug development and the global regulatory landscape, AAPS Annual Meeting, Washington, D.C., 2010.
48. J. Huang, G. Kaul, C. Cai, R. Chatlapalli, P. Hernandez-Abad, K. Ghosh, A. Nagi, Quality by design case study: An integrated multivariate approach to drug product and process development, International Journal of Pharmaceutics, 382, 23-32, 2009.
49. H. Wu, M.A. Khan, Quality-by-design (QbD): An integrated approach for evaluation of powder blending process kinetics and determination of powder blending end-point, Journal of Pharmaceutical Sciences, 98, 2784-2798, 2009.
50. A.S. Zidan, O.A. Sammour, M.A. Hammad, N.A. Megrab, M.J. Habib, M.A. Khan, Quality by design: Understanding the formulation variables of a cyclosporine A self-nanoemulsified drug delivery systems by Box-Behnken design and desirability function, International Journal of Pharmaceutics, 332, 55-63, 2007.
51. J. L'Hote-Gaston, R. Schmitt, Y. Li, C. Karas, Using polyethylene oxide blends to assess the effect of excipient variability: In formulation development of hydrophilic extended-release matrix tablets, Pharmaceutical Technology, 33, 36-41, 2009.
52. P.L. Stephenson, W.J. Thiel, The effect of humidity on the production of ordered mixtures, Powder Technology, 25, 115-119, 1980.
53. M.J. Crooks, R. Ho, Ordered mixing in direct compression of tablets, Powder Technology, 14, 161-167, 1976.
54. J.N. Staniforth, J.E. Rees, Electrostatic charge interactions in ordered powder mixes, Journal of Pharmacy and Pharmacology, 34, 69-76, 1982.
55. J.N. Staniforth, Ordered mixing or spontaneous granulation?, Powder Technology, 45, 73-77, 1985.
56. W.J. Thiel, L.T. Nguyen, F.J. Sberna, Content uniformity of microdose tablets (dosage 1 microgram-10 mg) produced by fluid bed granulation of interactive mixtures, Journal of Pharmacy and Pharmacology, 38, 335-343, 1986.
57. M. Song, N. Li, L.R. Tiedt, M.D. Degennaro, M.M. de Villiers, Preparation and characterization of highly porous direct compression carrier particles with improved drug loading during an interactive mixing process, AAPS PharmSciTech, 11, 698-707, 2010.
58. M. Song, M.M. de Villiers, Effect of a change in crystal polymorph on the degree of adhesion between micronized drug particles and large homogenous carrier particles during an interactive mixing process, Pharmaceutical Development and Technology, 9, 387-398, 2004.
59. D. Schulze, Powders and Bulk Solids: Behavior, Characterization, Storage and Flow, Springer, Berlin-Heidelberg-NewYork-Tokyo, 2008.
60. H. Schubert, Principles of agglomeration, Chemie Ingenieur Technik, 51, 266-277, 1979.
61. L.J. Jallo, Y. Chen, J. Bowen, F. Etzler, R. Dave, Prediction of inter-particle adhesion force from surface energy and surface roughness, Journal of Adhesion Science and Technology, 25, 367-384, 2011.
62. J. Yang, A. Sliva, A. Banerjee, R.N. Dave, R. Pfeffer, Dry particle coating for improving the flowability of cohesive powders, Powder Technology, 158, 21-33, 2005.
63. H.Y. Xie, The role of interparticle forces in the fluidization of fine particles, Powder Technology, 94, 99-108, 1997.
64. M.M. de Villiers, A.P. Lötter, J.G. van der Watt, Influence of surfactants and interactive mixing on the cohesiveproperties of a poorly wettable solid, Powder Technology, 75, 159-165, 1993.
65. P. Fridrun, Particle-Particle Adhesion in Pharmaceutical Powder Handeling, Imperial College Press, London, 1997.
66. J. Visser, An invited review: Van der waals and other cohesive forces affecting powder fluidization, Powder Technol, 58, 1-10, 1989.
67. M.S. Hassan, R. Lau, Inhalation performance of pollen-shape carrier in dry powder formulation with different drug mixing ratios: Comparison with lactose carrier, International Journal of Pharmaceutics, 386, 6-14, 2010.
68. A. Handoko, L. Ian, S.J. Peter, Influence of the polydispersity of the added fine lactose on the dispersion of salmeterol xinafoate from mixtures for inhalation, European Journal of Pharmaceutical Sciences, 36, 265-274, 2009.
69. E. Guenette, A. Barrett, D. Kraus, R. Brody, L. Harding, G. Magee, Understanding the effect of lactose particle size on the properties of DPI formulations using experimental design, International Journal of Pharmaceutics, 380, 80-88, 2009.
70. M.-P. Flament, P. Leterme, A. Gayot, The influence of carrier roughness on adhesion, content uniformity and the in vitro deposition of terbutaline sulphate from dry powder inhalers, International Journal of Pharmaceutics, 275, 201-209, 2004.
71. A.H. de Boer, P. Hagedoorn, D. Gjaltema, J. Goede, K.D. Kussendrager, H.W. Frijlink, Air classifier technology (ACT) in dry powder inhalation Part 2. The effect of lactose carrier surface properties on the drug-to-carrier interaction in adhesive mixtures for inhalation, International Journal of Pharmaceutics, 260, 201-216, 2003.
72. H.H.Y. Tong, B.Y. Shekunov, P. York, A.H.L. Chow, Predicting the aerosol performance of dry powder inhalation formulations by interparticulate interaction analysis using inverse gas chromatography, Journal of Pharmaceutical Sciences, 95, 228-233, 2006.
73. J.N. Staniforth, D.A.V. Morton, "Magnesium stearate, a phospholipid, or an amino acid in preparation of pharmaceutical particles for inhalation," in: W. 02/43700 (Ed.), 2002.
74. X.M. Zeng, G.P. Martin, S.-K. Tee, C. Marriott, The role of fine particle lactose on the dispersion and deaggregation of salbutamol sulphate in an air stream in vitro, International Journal of Pharmaceutics, 176, 99-110, 1998.
75. D. Ganderton, D.A.V. Morton, P. Lucas, "Improvements in or relating to powders," WO 00/33811, 2000.
76. D.A.V. Morton, M. Green, J.N. Staniforth, P. Begat, R. Price, P.M. Young, "The study of force control additives in creating high-performance dry powder inhaler formulations," in: Respiratory Drug Delivery VIII, Arizona, USA, 2002.
77. R. Vehring, Pharmaceutical particle engineering via spray drying, Pharmaceutical Research, 25, 999-1022, 2008.
78. J.J. Yang, C.Y. Liu, L.H. Quan, Y.H. Liao, Preparation and in vitro aerosol performance of spray-dried Shuang-Huang-Lian corrugated particles in carrier-based dry powder inhalers, AAPS PharmSciTech, 13, 816-825, 2012.
79. T. Sou, L.M. Kaminskas, T.-H. Nguyen, R. Carlberg, M.P. McIntosh, D.A.V. Morton, The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules, European Journal of Pharmaceutics Biopharmaceutics, 83, 234-243, 2013.
80. T. Sou, L. Orlando, M.P. McIntosh, L.M. Kaminskas, D.A.V. Morton, Investigating the interactions of amino acid components on a mannitol-based spray-dried powder formulation for pulmonary delivery: A design of experiment approach, International Journal of Pharmaceutics, 421, 220-229, 2011.
81. D. Lechuga-Ballesteros, M.C. Kuo, "Dry powder compositions having improved dispersivity," WO 01/32144, 2001.
82. S. Mangal, F. Meiser, S. Lakio, D. Morton, I. Larson, The role of physico-chemical and bulk characteristics of co-spray dried l-leucine and polyvinylpyrrolidone on glidant and binder properties in interactive mixtures, International Journal of Pharmaceutics, 479, 338-348, 2015.
83. N.Y.K. Chew, B.Y. Shekunov, H.H.Y. Tong, A.H.L. Chow, C. Savage, J. Wu, H.-K. Chan, Effect of amino acids on the dispersion of disodium cromoglycate powders, Journal of Pharmaceutical Sciences, 94, 2289-2300, 2005.
84. A.L. Feng, M.A. Boraey, M.A. Gwin, P.R. Finlay, P.J. Kuehl, R. Vehring, Mechanistic models facilitate efficient development of leucine containing microparticles for pulmonary drug delivery, International Journal of Pharmaceutics, 409, 156-163, 2011.
85. B.V. Derjaguin, V.M. Muller, Y.P. Toporov, Effect of contact deformations on the adhesion of particles, Journal of Colloid and Interface Science, 53, 314-326, 1975.
86. K.L. Johnson, K. Kendall, A.D. Roberts, Surface energy and the contact of elastic solids, Proceedings of The Royal Society Of London Series A-Mathematical And Physical Sciences, 324, 301-313, 1971.
87. F.M. Fowkes, Attractive forces at interfaces, Industrial & Engineering Chemistry Research, 56, 40-52, 1964.
88. C.J. van Oss, Acid-base interfacial interactions in aqueous media, Colloids and Surfaces A-Physicochemical and Engineering Aspects, 78, 1-49, 1993.
89. C.J. Van Oss, R.J. Good, M.K. Chaudhury, Additive and nonadditive surface tension components and the interpretation of contact angles, Langmuir, 4, 884-891, 1988.
90. P. Begat, R. Price, H. Harris, D.A.V. Morton, J.N. Staniforth, The influence of force control agents on the cohesive-adhesive balance in dry powder inhaler formulations, KONA Powder Particle Journal, 23, 109-1231, 2005.
91. P. Begat, D.A.V. Morton, J. Staniforth, R. Price, The cohesive-adhesive balances in dry powder inhaler formulations II: Influence on fine particle delivery characteristics, Pharmaceutical Research, 21, 1826-1833, 2004.
92. N.Y.K. Chew, P. Tang, H.K. Chan, J.A. Raper, How much particle surface corrugation is sufficient to improve aerosol performance of powders?, Pharmaceutical Research, 22, 148-152, 2005.
93. C.M. Minchom, N.A. Armstrong, A proposed technique for expressing the capacity of directly compressible tablet diluents, Journal of Pharmacy and Pharmacology, 39, 69, 1989.
94. N.A. Armstrong, "Tablet manufacture by direct compression," in: J. Swarbrick, ed., Encyclopedia of Pharmaceutical Technology, Informa Healthcare, USA, 2007, pp. 3673-3683.
95. Y. Kato, M. Ohkuma, Y. Shimada, H. Sunada, Evaluation of the flowability of surface-modified preparations by the measurement of the inter-particle adhesive force, Journal of Drug Delivery Science and Technology, 15, 217-221, 2005
96. J.N. Staniforth, "Powder flow," in: M.E. Aulton, ed., Pharmaceutics: The Science of Dosage Form Design, Churchill Livingstone, pp. 197-210, 2002.
97. N. Harnby, A.E. Hawkins, D. Vandame, The use of bulk density determination as a means of typifying the flow characteristics of loosely compacted powders under conditions of variable relative humidity, Chemical Engineering Science, 42, 879-888, 1987.
98. A. Castellanos, The relationship between attractive interparticle forces and bulk behaviour in dry and uncharged fine powders, Advances in Physics, 54, 263-376, 2005.
99. S. Jonat, P. Albers, A. Gray, P.C. Schmidt, Investigation of the glidant properties of compacted colloidal silicon dioxide by angle of repose and X-ray photoelectron spectroscopy, European Journal of Pharmaceutics Biopharmaceutics, 63, 356-359, 2006.
100. S. Jonat, S. Hasenzahl, A. Gray, P.C. Schmidt, Mechanism of glidants: Investigation of the effect of different colloidal silicon dioxide types on powder flow by atomic force and scanning electron microscopy, Journal of Pharmaceutical Sciences, 93, 2635-2644, 2004.
101. K. Meyer, I. Zimmermann, Effect of glidants in binary powder mixtures, Powder Technology, 139, 40-54, 2004.
102. S. Jonat, S. Hasenzahl, M. Drechsler, P. Albers, K.G. Wagner, P.C. Schmidt, Investigation of compacted hydrophilic and hydrophobic colloidal silicon dioxides as glidants for pharmaceutical excipients, Powder Technology, 141, 31-43, 2004.
103. J.T. Fell, J.M. Newton, Determination of tablet strength by the diametral-compression test, Journal of Pharmaceutical Sciences, 59, 688-691, 1970.
104. U.S.P. Convention, General Chapter <1217> Tablet Breaking Force, The United States Pharmacopeial Convention, Rockville, 2009.
105. K.G. Pitt, M.G. Heasley, Determination of the tensile strength of elongated tablets, Powder Technology, 238, 169-175, 2013.
106. G. Röscheisen, P.C. Schmidt, Preparation and optimization of l-leucine as lubricant for effervescent tablet formulations, Pharmaceutica ACTA Helvetiae, 70, 133-139, 1995.
107. I. Ilić, B. Govedarica, R. Šibanc, R. Dreu, S. Srčič, Deformation properties of pharmaceutical excipients determined using an in-die and out-die method, International Journal of Pharmaceutics, 446, 6-15, 2013.